Related references
Note: Only part of the references are listed.Causes of Death After Neuroendocrine Tumors Diagnosis A US Population-Based Analysis
Mohamad Bassam Sonbol et al.
PANCREAS (2021)
Risk of Cancer-Specific Death for Patients Diagnosed With Neuroendocrine Tumors: A Population-Based Analysis
Julie Hallet et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
Jason S. Starr et al.
ONCOTARGETS AND THERAPY (2020)
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
Thorvardur R. Halfdanarson et al.
PANCREAS (2020)
Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
Annunziata Di Domenico et al.
COMMUNICATIONS BIOLOGY (2020)
Epidemiologic Signatures in Cancer
H. Gilbert Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
Pamela L. Kunz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
Simron Singh et al.
JAMA ONCOLOGY (2018)
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
Chang S. Chan et al.
NATURE COMMUNICATIONS (2018)
Whole-genome landscape of pancreatic neuroendocrine tumours (vol 543, pg 65, 2017)
Aldo Scarpa et al.
NATURE (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
Thorvardur R. Halfdanarson et al.
ENDOCRINE-RELATED CANCER (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Incidence and management of malignant digestive endocrine tumours in a well defined French population
C Lepage et al.
GUT (2004)
Share Paper
